The global Clinical
Decision Support System Market by Products (Stand Alone CDSS and Integrated
CDSS), by Component (Hardware, Software, and Services), by Mode of Delivery (On
Premise CDSS and Cloud based CDSS), by Application (Diagnosis Support,
Prescription Support, Clinical Alert and Clinical Guideline, and Others), by
End User (Hospitals, Ambulatory Centers, Clinics, and Others ), and by Region
(North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
was valued at US$ 767.4 million in 2017, and is projected to exhibit a CAGR of
11.69% over the forecast period (2018 – 2026).
Clinical decision support is a
process for enhancing health-related decisions and actions with structured
clinical knowledge and patient information to improve health and healthcare
delivery. Various stakeholder in information exchange are physicians, nurses,
patients, and others involved in patient care delivery. Clinical support system
delivers clinical knowledge, guideline based inputs, and intelligently processed
actionable patient data (e.g. Drug interaction events for specific patient in
past which would be shown at CDSS handled by physician). Furthermore, it
provides data and order entry facilities, reference information, clinical
alerts, and others. Increasing incidences of medication errors and hospital
readmission due to inadequate health outcome are expected to promote wide
adoption of the clinical decision support system. According to World Health
Organization (WHO) report, in 2017, medication error cost around US$ 42 billion
annually worldwide. An estimated 43 million patient safety incidence occurs
annually. According to the Agency for Healthcare Research and Quality’s (AHRQ)
Healthcare Cost and Utilization Project in 2011, around 3.3 million adult hospital
readmissions were reported within 30-day in the U.S. due to all-causes(e.g.
Heart attack, Heart failure, Pneumonia and Chronic obstructive pulmonary
disease etc.) and it inculcated cost of around US$ 41.3 billion. Clinical
decision support systems is expected to witness significant growth in developed
economies such as North America and Europe. Healthcare legislations such as
Protecting Access to Medicare Act (PAMA), which was passed in 2014 and took
effect from 2017, PAMA pleads for EHR based Incentive Reimbursement Program by
applying principle of ‘Meaningful Use’. For instance, under this law, providers
of radiology services will be required to offer CDSS to ordering physicians.
The law says that the physicians who provide diagnostic interpretation will be
paid only for those claims that confirm a certified CDSS was used.
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2054
New product launches,
collaborations, and acquisitions by key players are expected to drive growth of
the clinical decision support system market
Key players are launching
innovative products in the endoscopy market in order to maintain leading
position in market. These new products could be easily integrated with
Electronic Health Record (EHR), Computerized Physician Order Entry (CPOE)
system thereby avoiding duplication of work. New systems has cloud-based
support system that allows CDSS to get updated continuously for new clinical
data, evidence and other information to help in prescription, diagnosis thereby
providing quality health care. In 2017, Change Healthcare launched the new
version of InterQual clinical decision support system, which consist of
Medicare Procedures (U.S. State insurance) with efficient set of criteria,
review, and other features that better help decision-making. For instance, this
system Centers for Medicare & Medicaid Service’s geometric mean length of
stay data that provide target length of stay for Medicare beneficiary. It has
more automation and knowledge-based search features and large drug registry.
Browse 31 Market Data Tables and
35 Figures spread through 177 Pages and in-depth TOC on “Clinical Decision and
Support System Market”- by Products (Stand Alone CDSS and Integrated CDSS), by
Component (Hardware, Software and Services), by Mode of Delivery (On Premise
CDSS and Cloud based CDSS), by Application (Diagnosis Support, Prescription
Support, Clinical Alert and Clinical Guideline and Others), by End User
(Hospitals, Ambulatory Centers, Clinics and Others ), and by Region (North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Market players are undergoing
strategic collaborations and leveraging each other’s strength to offer
innovative product. In July 2018, Cerner and Lumeris, announced a 10-year
strategic collaborations to provide solutions to eliminate inefficiencies in
the current health care system. Through this collaborations two companies would
launch product named Maestro Advantage. This new product would provide
actionable data and insights with healthcare provider workflows, combining
existing investment in digitized data and processes. Maestro Advantage would
help physician to effectively assess risk and create interventions and better
maximize outcomes for patients In June 2018, Allscripts and MedAware, which is
Israeli patient safety solutions announced that both companies are developing
medication-related decision support at the point of care. Through this
collaborations, Allscripts' dbMotion solution would be having point of care
intervention solution of MedAware. This intervention use Artificial
Intelligence to monitor a patient's medications and clinical records, which
could reduce medication-related risks (adverse drug events or a patient's risk
of developing opioid dependency)
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/clinical-decision-and-support-system-market-2054
Key Takeaways of the Clinical
Decision and Support System Market:
The global clinical decision
support system market is expected to exhibit a CAGR of 11.69% over the forecast
period, owing to increasing awareness regarding benefits of CDSS, increasing
incidence of medical error, hospital readmissions, and adverse drug event
Among product type, integrated
clinical decision support system segment is expected to hold dominant position
in the market, as electronic health record and computerized physician order
entry are majorly updated for integrating with CDSS to provide better clinical
judgment, and provide benefit of synergy. Among component, service segment is
expected to dominate the market, as cloud-based services are expected to
witness significant growth. Among mode of delivery, cloud-based system segment
is expected to dominate the market, owing to increasing adoption of cloud based
health IT solutions by healthcare provider
Among end users, hospitals
segment holds dominant position in market, as increasing complex data base with
specialized need of care for each patient and vast database generated in the
process demands for comprehensive and evidence based input to provide quality
care to patients.
North America is expected to be
the dominant region in the clinical decision support system market, followed by
Europe. The U.S. invests major amount over healthcare in the world, and it is
focused to provide value-based care, which could be attended effectively by
implementing CDSS. Value based care involves providers to be paid based on
patient health outcomes which means providers are rewarded if patients improve
their health, reduce the effects and incidence of chronic disease. CDSS would
be important in this value based care ecosystem. Key players are also launching
new products into market, which is expected to propel growth of market in the
region.
Key players operating in the
clinical decision support system market include Cerner Corporation, Allscripts
Healthcare Solutions, Inc., IBM Watson Health, GE Healthcare, Change
Healthcare, Zynx Health, Carestream Health Inc., First Databank, Inc., NextGen
Healthcare Information Systems, Agfa Healthcare, Medical Information Technology
Inc., Athena Health, Wolters Kluwer NU, Siemens Healthineers, and Philips
Healthcare.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2054
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment